egnite’s Call for Science Study on M-TEER Device Durability and Long-Term Patient Outcomes to be Featured at TCT 2026

egnite’s Call for Science Study on M-TEER Device Durability and Long-Term Patient Outcomes to be Featured at TCT 2026

The egnite Registry contributed de-identified, longitudinal data, linking serial echocardiograms with clinical outcomes, to help answer what happens to patients after a successful mitral transcatheter edge-to-edge repair (M-TEER) procedure. 

ALISO VIEJO, Calif. — October 13, 2026 — egnite, Inc., a cardiovascular intelligence company that helps clinicians identify and manage patients with untreated heart disease, today announced that Dr. John T. Saxon, Director of the Advanced Cardiac Valve Center at University of Virginia (UVA) Health, has been selected as the winner of its inaugural Call for Science grant program. His study, Long-Term Durability After Successful M-TEER: Insights from a Large, Real-World Imaging Database, will be presented as Featured Clinical Research at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego on October 31, 2026, at 11:15 a.m. PT. 

The Call for Science is an investigator-initiated study (IIS) program that invited U.S.-based researchers to submit original study proposals using the egnite Registry, which includes de-identified data from approximately 14 million patients and 6 million echocardiograms. Selected research receives analytical support from egnite’s data science team. 

Dr. Saxon’s study draws on approximately 6,000+ patients who underwent M-TEER. Of those, more than 2,000 had successful procedures and were followed for up to three years, with serial echocardiograms and clinical outcomes used to measure device durability and its effect on patients. 

Read the Full Release